A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward
Wang, Bo, Van Oekelen, Oliver, Mouhieddine, Tarek H, Del Valle, Diane Marie, Richter, Joshua, Cho, Hearn Jay, Richard, Shambavi, Chari, Ajai, Gnjatic, Sacha, Merad, Miriam, Jagannath, Sundar, Parekh, Samir, Madduri, Deepu
Published in Journal of hematology and oncology (14.07.2020)
Published in Journal of hematology and oncology (14.07.2020)
Get full text
Journal Article
Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma
Richter, Joshua, Neparidze, Natalia, Zhang, Lin, Nair, Shiny, Monesmith, Tamara, Sundaram, Ranjini, Miesowicz, Fred, Dhodapkar, Kavita M., Dhodapkar, Madhav V.
Published in Blood (17.01.2013)
Published in Blood (17.01.2013)
Get full text
Journal Article
A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma
Mikhael, Joseph, Richter, Joshua, Vij, Ravi, Cole, Craig, Zonder, Jeffrey, Kaufman, Jonathan L., Bensinger, William, Dimopoulos, Meletios, Lendvai, Nikoletta, Hari, Parameswaran, Ocio, Enrique M., Gasparetto, Cristina, Kumar, Shaji, Oprea, Corina, Chiron, Marielle, Brillac, Claire, Charpentier, Eric, San-Miguel, Jesús, Martin, Thomas
Published in Leukemia (01.12.2020)
Published in Leukemia (01.12.2020)
Get full text
Journal Article
Blood Transfusion Management for Patients Treated With Anti-CD38 Monoclonal Antibodies
Lancman, Guido, Arinsburg, Suzanne, Jhang, Jeffrey, Cho, Hearn Jay, Jagannath, Sundar, Madduri, Deepu, Parekh, Samir, Richter, Joshua, Chari, Ajai
Published in Frontiers in immunology (15.11.2018)
Published in Frontiers in immunology (15.11.2018)
Get full text
Journal Article
Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis
Premkumar, Vikram J., Lentzsch, Suzanne, Pan, Samuel, Bhutani, Divaya, Richter, Joshua, Jagannath, Sundar, Liedtke, Michaela, Jaccard, Arnaud, Wechalekar, Ashutosh D., Comenzo, Raymond, Sanchorawala, Vaishali, Royer, Bruno, Rosenzweig, Michael, Valent, Jason, Schönland, Stefan, Fonseca, Rafael, Wong, Sandy, Kapoor, Prashant
Published in Blood cancer journal (New York) (11.01.2021)
Published in Blood cancer journal (New York) (11.01.2021)
Get full text
Journal Article
Atypical IgG4+ Plasmacytic Proliferations and Lymphomas
Bledsoe, Jacob R, Wallace, Zachary S, Deshpande, Vikram, Richter, Joshua R, Klapman, Jason, Cowan, Andrew, Stone, John H, Ferry, Judith A
Published in American journal of clinical pathology (01.09.2017)
Published in American journal of clinical pathology (01.09.2017)
Get full text
Journal Article
Editorial: T-cell directed therapies in multiple myeloma
Richter, Joshua, Anderson, Jr, Larry D, Ramasamy, Karthik, Rossi, Adriana
Published in Frontiers in oncology (16.06.2023)
Published in Frontiers in oncology (16.06.2023)
Get full text
Journal Article
B-cell maturation antigen (BCMA) in multiple myeloma: the new frontier of targeted therapies
Sanchez, Larysa, Dardac, Alexandra, Madduri, Deepu, Richard, Shambavi, Richter, Joshua
Published in Therapeutic Advances in Hematology (01.01.2021)
Published in Therapeutic Advances in Hematology (01.01.2021)
Get full text
Book Review
Journal Article
Selinexor in relapsed/refractory multiple myeloma
Richter, Joshua, Madduri, Deepu, Richard, Shambavi, Chari, Ajai
Published in Therapeutic Advances in Hematology (01.01.2020)
Published in Therapeutic Advances in Hematology (01.01.2020)
Get full text
Book Review
Journal Article
A phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma
Cornell, Robert Frank, Baz, Rachid, Richter, Joshua R., Rossi, Adriana, Vogl, Dan T., Chen, Christine, Shustik, Chaim, Alvarez, Mariano J., Shen, Yao, Unger, T. J., Ben‐Shahar, Osnat, Wang, Hongwei, Baloglu, Erkan, Senapedis, William, Ma, Xiwen, Landesman, Yosef, Bai, Xiang, Bader, Justin, Xu, Hongmei, Marshall, Tracey, Chang, Hua, Walker, Christopher J., Shah, Jatin, Shacham, Sharon, Kauffman, Michael G., Hofmeister, Craig C.
Published in American journal of hematology (01.02.2022)
Published in American journal of hematology (01.02.2022)
Get full text
Journal Article
Phase I study of carfilzomib, lenalidomide, vorinostat, and dexamethasone in patients with relapsed and/or refractory multiple myeloma
Vesole, David H., Bilotti, Elizabeth, Richter, Joshua R., McNeill, Ann, McBride, Laura, Raucci, Laura, Anand, Palka, Bednarz, Urszula, Ivanovski, Kristin, Smith, Judith, Batra, Veena, Aleman, Adolfo, Sims, Taliah, Guerrero, Laura, Mato, Anthony, Siegel, David S.
Published in British journal of haematology (01.10.2015)
Published in British journal of haematology (01.10.2015)
Get full text
Journal Article
A phase IIb trial of vorinostat in combination with lenalidomide and dexamethasone in patients with multiple myeloma refractory to previous lenalidomide‐containing regimens
Sanchez, Larysa, Vesole, David H., Richter, Joshua R., Biran, Noa, Bilotti, Elizabeth, McBride, Laura, Anand, Palka, Ivanovski, Kristin, Siegel, David S.
Published in British journal of haematology (01.02.2017)
Published in British journal of haematology (01.02.2017)
Get full text
Journal Article
Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study
Tremblay, Gabriel, Daniele, Patrick, Breeze, Janis, Li, Lingling, Shah, Jatin, Shacham, Sharon, Kauffman, Michael, Engelhardt, Monika, Chari, Ajaj, Nooka, Ajay, Vogl, Dan, Gavriatopoulou, Maria, Dimopoulos, Meletios-Athanasios, Richardson, Paul, Biran, Noa, Siegel, David, Vlummens, Philip, Doyen, Chantal, Facon, Thierry, Mohty, Mohamad, Meuleman, Nathalie, Levy, Moshe, Costa, Luciano, Hoffman, James E, Delforge, Michel, Kaminetzky, David, Weisel, Katja, Raab, Marc, Dingli, David, Tuchman, Sascha, Laurent, Frenzel, Vij, Ravi, Schiller, Gary, Moreau, Philippe, Richter, Joshua, Schreder, Martin, Podar, Klaus, Parker, Terri, Cornell, Robert Frank, Lionel, Karlin, Choquet, Sylvain, Sundar, Jagannath
Published in BMC cancer (06.09.2021)
Published in BMC cancer (06.09.2021)
Get full text
Journal Article
In-class transition (iCT) of proteasome inhibitor-based therapy: a community approach to multiple myeloma management
Rifkin, Robert M., Girnius, Saulius K., Noga, Stephen J., Birhiray, Ruemu E., Kambhampati, Suman, Manda, Sudhir, Lyons, Roger M., Yimer, Habte A., Cherepanov, Dasha, Lloyd, Eric, Whidden, Presley, Richter, Joshua
Published in Blood cancer journal (New York) (19.09.2023)
Published in Blood cancer journal (New York) (19.09.2023)
Get full text
Journal Article
Matching‐adjusted indirect comparison of isatuximab plus carfilzomib and dexamethasone with daratumumab plus lenalidomide and dexamethasone in relapsed multiple myeloma
Richter, Joshua, Lin, Peggy L., Garcia‐Horton, Viviana, Guyot, Patricia, Singh, Erin, Zhou, Zheng‐Yi, Sievert, Mark, Taiji, Riley
Published in Cancer medicine (Malden, MA) (01.04.2023)
Published in Cancer medicine (Malden, MA) (01.04.2023)
Get full text
Journal Article
PB1932: RETROSPECTIVE STUDY OF BURDEN OF INFECTION IN PATIENTS WITH AND WITHOUT SECONDARY IMMUNODEFICIENCY DISEASE FOLLOWING DIAGNOSIS OF CHRONIC LYMPHOCYTIC LEUKAEMIA
Davids, Matthew, Richter, Joshua, Anderson‐Smits, Colin, Kamieniak, Marta, Ren, Kaili, Shah, Drishti, Siffel, Csaba
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article